All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-33136751

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	33136751	E138A	RT	gag-pol	HIV Infections	D G C L	View
2	33136751	E138E	RT	gag-pol	HIV Infections	D G C L	View
3	33136751	E138K	RT	gag-pol	HIV Infections	D G C L	View
4	33136751	E138T	RT	gag-pol	HIV Infections	D G C L	View
5	33136751	G140R	IN	gag-pol	HIV Infections	D G C L	View
6	33136751	G190S	RT	gag-pol	HIV Infections	D G C L	View
7	33136751	K101E	RT	gag-pol	HIV Infections	D G C L	View
8	33136751	L74I	IN	gag-pol	HIV Infections	D G C L	View
9	33136751	M184I	RT	gag-pol	HIV Infections	D G C L	View
10	33136751	M184V	RT	gag-pol	HIV Infections	D G C L	View
11	33136751	M230I	RT	gag-pol	HIV Infections	D G C L	View
12	33136751	M230M	RT	gag-pol	HIV Infections	D G C L	View
13	33136751	N155H	IN	gag-pol	HIV Infections	D G C L	View
14	33136751	Q148R	IN	gag-pol	HIV Infections	D G C L	View
15	33136751	V108I	RT	gag-pol	HIV Infections	D G C L	View
16	33136751	V108V	RT	gag-pol	HIV Infections	D G C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.